has been cited by the following article(s):
[1]
|
Cost-Utility Analysis of First-Line Pemetrexed Plus Cisplatin in Non-Small Cell Lung Cancer in Thailand
Value in Health Regional Issues,
2020
DOI:10.1016/j.vhri.2019.04.005
|
|
|
[2]
|
WILLINGNESS TO PAY FOR LUNG CANCER TREATMENT: PATIENT VERSUS GENERAL PUBLIC VALUES
International Journal of Technology Assessment in Health Care,
2015
DOI:10.1017/S0266462315000409
|
|
|